Table 1.
Baseline characteristics of the three groups
| Index | Group1 | Group2 | Group3 | F | P |
| (n = 38) | (n = 19) | (n = 19) | value | value | |
| Male/Female | 26/12 | 13/6 | 13/6 | 0.000 | 1.000 |
| Age (yr) | 14.04 ± 1.8 | 13.4 ± 2.5 | 13.4 ± 1.6 | 0.904 | 0.410 |
| BMI (kg/m2) | 29.81 ± 2.41 | 29.61 ± 1.48 | 29.36 ± 3.11 | 0.223 | 0.800 |
| ZBMI | 3.53 ± 1.17 | 3.02 ± 0.39 | 3.44 ± 1.57 | 1.268 | 0.287 |
| ALT (IU/L) | 144.77 ± 26.73 | 152.26 ± 49.30 | 139.98 ± 19.82 | 0.711 | 0.495 |
| AST (IU/L) | 86.63 ± 21.54 | 93.26 ± 38.94 | 78.55 ± 23.11 | 1.432 | 0.245 |
| TG (mmol/L) | 1.44 ± 0.35 | 1.38 ± 0.38 | 1.51 ± 0.33 | 0.698 | 0.501 |
| TCHO (mmol/L) | 4.70 ± 1.18 | 4.82 ± 0.91 | 4.61 ± 1.03 | 0.200 | 0.819 |
| FBG (mmol/L) | 4.26 ± 0.42 | 4.15 ± 0.39 | 4.22 ± 0.43 | 0.527 | 0.592 |
| FINS (IU/L) | 15.50 ± 2.10 | 15.54 ± 4.50 | 15.42 ± 1.10 | 0.011 | 0.989 |
| HOMA-IR | 2.93 ± 0.44 | 2.87 ± 0.88 | 2.89 ± 0.32 | 0.087 | 0.917 |
BMI: Body mass index; ALT: Plasma alanine aminotransferase; AST: Aspartate aminotransferase; TG: Triglyceride; TCHO: Total cholesterol; FBG: Fasting blood glucose; FINS: Fasting serum insulin; HOMA-IR: Homeostasis model assent-insulin resistance; Group 1: Receiving no intervention as control; Group 2: Taking no drug and treated only with lifestyle intervention at summer camp; Group 3: Taking vitamin E, and controlled lifestyle intervention at home.